| NCT ID | NCT05776316 |
| Status | Recruiting |
| Phase | — |
| Sponsor | NYU Langone Health |
| Condition | Drug Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 200 participants |
| Start Date | 2024-11-25 |
| Primary Completion | 2026-09-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 200 participants in total. It began in 2024-11-25 with a primary completion date of 2026-09-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to assess whether an integrated harm reduction intervention (IHRI), compared to harm reduction (HR) services as usual, will improve harm reduction service utilization among Black and Latinx people who use drugs (PWUD).
Eligibility Criteria
Inclusion Criteria: * at least 18 years of age * self-identified as misusing opioids +/- other substances (stimulants) in the past 30 days, confirmed by interview using DSM-5 criteria * English or Spanish speaking * able to provide informed consent. Exclusion Criteria: * inability to provide informed consent or participate in the study procedures as proposed in the consent * active suicidal or homicidal ideation or an unstable psychotic disorder (schizophrenia, schizoaffective disorder) or mood disorder (bipolar disorder, severe major depressive disorder) * an unwillingness to be randomized. * are prisoners
Contact & Investigator
Ayana Jordan, MD, PhD
PRINCIPAL INVESTIGATOR
NYU Langone Health
Frequently Asked Questions
Who can join the NCT05776316 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Drug Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05776316 currently recruiting?
Yes, NCT05776316 is actively recruiting participants. Contact the research team at Ayana.Jordan@nyulangone.org for enrollment information.
Where is the NCT05776316 trial being conducted?
This trial is being conducted at New Haven, United States, New York, United States, Orangeburg, United States.
Who is sponsoring the NCT05776316 clinical trial?
NCT05776316 is sponsored by NYU Langone Health. The principal investigator is Ayana Jordan, MD, PhD at NYU Langone Health. The trial plans to enroll 200 participants.